SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 147 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $50,000 | -49.5% | 29,120 | -48.9% | 0.00% | – |
| Q2 2018 | $99,000 | +11.2% | 56,996 | +16.7% | 0.00% | – |
| Q1 2018 | $89,000 | -67.8% | 48,826 | -60.6% | 0.00% | – |
| Q4 2017 | $276,000 | -73.2% | 123,866 | -65.1% | 0.00% | -100.0% |
| Q3 2017 | $1,030,000 | -23.0% | 355,043 | +18.0% | 0.00% | -50.0% |
| Q2 2017 | $1,338,000 | +15.1% | 300,781 | +20.7% | 0.00% | 0.0% |
| Q1 2017 | $1,162,000 | +92.4% | 249,276 | +151.4% | 0.00% | +100.0% |
| Q4 2016 | $604,000 | +45.5% | 99,146 | +31.6% | 0.00% | 0.0% |
| Q3 2016 | $415,000 | +64.0% | 75,346 | +13.2% | 0.00% | – |
| Q2 2016 | $253,000 | +216.2% | 66,568 | +131.0% | 0.00% | – |
| Q1 2016 | $80,000 | -70.9% | 28,818 | -40.6% | 0.00% | – |
| Q4 2015 | $275,000 | +2.6% | 48,535 | -4.1% | 0.00% | -100.0% |
| Q3 2015 | $268,000 | -56.9% | 50,585 | -32.5% | 0.00% | 0.0% |
| Q2 2015 | $622,000 | +206.4% | 74,990 | +70.7% | 0.00% | – |
| Q1 2015 | $203,000 | +395.1% | 43,942 | +228.3% | 0.00% | – |
| Q4 2014 | $41,000 | -46.1% | 13,383 | -6.4% | 0.00% | – |
| Q1 2014 | $76,000 | +11.8% | 14,298 | +17.8% | 0.00% | – |
| Q4 2013 | $68,000 | -79.7% | 12,134 | -83.4% | 0.00% | -100.0% |
| Q3 2013 | $335,000 | +570.0% | 73,218 | +534.9% | 0.00% | – |
| Q2 2013 | $50,000 | – | 11,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|